ANYA KACZMAREK: Open Payments
NPI 1578751053 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,271 in 53 payments from 15 companies in 2025. Trend: 2023 $1,157 · 2024 $1,341 · 2025 $1,271
Food & beverage: $1,271
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $384 |
| GENZYME CORPORATION | 6 | $194 |
| LEO Pharma Inc. | 6 | $131 |
| Regeneron Healthcare Solutions, Inc. | 3 | $101 |
| ABBVIE INC. | 4 | $82 |
| Organon LLC | 7 | $78 |
| Galderma Laboratories, L.P. | 3 | $55 |
| Janssen Biotech, Inc. | 2 | $52 |
| Amgen Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
Products named: Bimzelx, DUPIXENT, ADBRY, VTAMA, NEMLUVIO, TREMFYA, Cimzia, OTEZLA.
Industry payments across AZ — which companies pay providers there.
